Back to Top ↑2021 Symposium Sessions |
| Monday October 18 |
1:30 | Nanomedicine |
| Tuesday October 19 |
8:30 | Biotech & Medtech Track Keynotes |
10:30 | Innovations in Diagnostics I |
1:30 | Innovations in Diagnostics II |
4:00 | Nanomedicine - Posters |
| Wednesday October 20 |
10:30 | Applied Biomaterials: Drug/Gene Delivery |
1:30 | New Nano Delivery Technologies |
|
2021 Symposium Program |
| Monday October 18 |
|
1:30 | Nanomedicine | Woodrow Wilson B |
| Session chair: Thomas J. Webster, Interstellar Therapeutics & Steve Zullo, National Institute of Biomedical Imaging and Bioengineering |
1:30 | 4D printed nano biomaterials: Applications for on-demand drug delivery, improved tissue growth, stem cell delivery, and so much more T.J. Webster, Interstellar Therapeutics, US |
1:55 | Janus Base Nanopieces for Intracellular Delivery and Endosomal Escape Y. Chen, University of Connecticut,, US |
2:20 | Cold Atmospheric Plasma (CAP) Mediated Bacteria Inactivation and Removal of Biofilms: A Combination of Experiments and Computational Modeling M. Wang, M. Gao, T.J. Webster, Massachusetts Institute of Technology, US |
2:45 | Delivering Therapeutic Heat to Solid Tumors: Bringing Practical Photothermal Therapy to the Clinic L. Pagliaro, Siva Therapeutics, Inc., US |
3:10 | Combination therapy using brain accumulating polymeric nanoparticles for tackling HIV-infected brain reservoirs in drug abuse population N. Kolishetti, B. Surnar, A.S. Shah, R. Ramirez-Jaime, V. Atluri, A.Y. Arias, M. Nair, S. Dhar, Florida International University, US |
3:30 | Nanocomposite Motion Tape for Distributed Skin-Strain, Muscle Engagement, and Movement Assessment, pp. 192-195 Y-A Lin, K.J. Loh, University of California, San Diego, US |
3:50 | Field-activated Magnetic Nanocubes for Remotely-controlled Cell-based Therapy J. Beltran-Huarac, B. Thapa, D.N. Yamaleyeva, A.V. Kabanov, East Carolina University, US |
4:10 | Titanium dioxide nanoparticles modulate the production of immune mediators associated with lepromatous leprosy by human dendritic cells upon infection with Mycobacterium leprae S. Warren, J. Barragan, S.Y. Lee, R. Siddiqui, A Serizawa, and J. Cervantes, Texas Tech University Health Sciences Center, US |
| Tuesday October 19 |
|
8:30 | Biotech & Medtech Track Keynotes | Woodrow Wilson C |
| Session chair: Jeannine Coburn, Worcester Polytechnic Institute |
8:30 | Integrating Nanotechnology with 3D Bioprinting for Vascularized Tissue Regeneration H. Cui, T. Esworthy, L.G. Zhang, The George Washington University, US |
9:00 | Innovation in Interbody Spinal Fusion Implants with Porous and Bioactive Composites: The Journey from Concept to Commercialization R.K. Roeder, University of Notre Dame, US |
9:30 | Accessing Intracellular Targets for Therapeutic Gain in Major Diseases S. Dhar, University of Miami, US |
|
10:30 | Innovations in Diagnostics I | Magnolia 3 |
| Session chair: Prakash Nallathamby, University of Notre Dame |
10:30 | Engineering Nanoparticle Probes for Detecting Disease and Monitoring Therapy with Computed Tomography R.K. Roeder, T.E. Curtis, C.J. Evans, T.A. Finamore, L. Li, T.L. McGinnity, P.D. Nallathamby, University of Notre Dame, US |
10:55 | Multifunctional Dendronized Nanoparticles for Cancer Therapies M-C. Daniel, University of Maryland Baltimore County, US |
11:20 | Non-Specific Gold Nanoparticle – Blood Serum Protein Interactions: Not Foe, but Powerful Tool for In Vitro Diagnostic Applications Q. Huo, University of Central Florida, US |
11:45 | Glycation of the lipoprotein ApoAI is a novel biomarker for early predicting diabetic cardiovascular complications A. Arias-Alvarado, S. Ilchenko, E. Reed, S. Kashyap, T. Kasumov, Northeast Ohio Medical University, US |
|
1:30 | Innovations in Diagnostics II | Magnolia 2 |
| Session chair: Prakash Nallathamby, University of Notre Dame |
1:30 | MALDI Imaging: Taking Biomedical Research to the Next Level of Molecular Microscopy C. Tressler, Johns Hopkins School of Medicine, US |
1:55 | Microbubbling Digital Assay P. Wang, University of Pennsylvania, US |
2:15 | PEST-enabled Precision Medicine Platform for Viral Diagnostics and Therapeutics X. Wang, S. Yao, Atom Bioworks, US |
2:35 | A Bioaffinity Approach to Circulating Tumor Cells Capture K. Morris, C. Bilynsky, A.-L. Papa, The George Washington University, US |
|
4:00 | Nanomedicine - Posters | Expo Hall AB |
| Roboplasmid: A remotely programmable plasmid for rapid viral inactivation, pp. 157-160 A. Kalra, K. Jayarapu, Carmel High School, US |
| Microbial Synthesis and Characterization of Silver Nanoparticles by Lactococcus lactis TNM-B1 and Its Antimicrobial Properties M.B. Osho, A.O. Precious-Egere, A.O. Awotula, McPherson University, NG |
| Wednesday October 20 |
|
10:30 | Applied Biomaterials: Drug/Gene Delivery | Baltimore 4 |
| Session chair: Jeannine Coburn, Worcester Polytechnic Institute |
10:30 | Examining and exploiting lymphatic vessels for drug delivery at mucosal surfaces K. Maisel, University of Maryland, US |
11:00 | Identifying the cytosolic fate of DNA nanostructures D. Mathur, K. Rogers, S.A. Díaz, M. Muroski, W.P. Klein, L. Field, J.B. Delehanty, I.L. Medintz, George Mason University, US |
11:20 | Novel Guidewire Design and Coating for Continuous Delivery of Adenosine During Interventional Procedures E. Brewer, Z. Brown, M. Foreman, A. Lowman, E. Menshikova, E. Jackson, Rowan University, US |
|
1:30 | New Nano Delivery Technologies | Baltimore 4 |
| Session chair: Puneet Tyagi, AstraZeneca & Steve Zullo, National Institute of Biomedical Imaging and Bioengineering |
1:30 | Nanotechnology-based Tools for Addressing Viral and Cardiovascular Diseases in Pregnant Women S. Dhar, University of Miami, US |
1:55 | Targeted Transport of Plant Growth Promoting Rhizobacteria by Soil Protists L.M. Shor, C. Hawxhurst, J.L. Micciulla, D.J. Gage, University of Connecticut, US |
2:15 | The Development of Quick-Set, High-Solids Pharmaceutical Tablet Coatings T. Kalantar, M. Ladika, H. Shao, S. Dean, K. Harris, P. Sheskey, K. Coppens, K. Balwinski, D. Holbrook, Dow, Inc., US |
2:35 | mRNA: from addressing global pandemics to medicines of the future L. Santos, AstraZeneca, US |
3:00 | Investigation of Lyophilized Platelet Interactions with Human Platelets In Vitro B. Schnoor, A.-L. Papa, George Washington University, US |
3:20 | A Cancer-Favoring, Engineered Vaccinia Virus for Cholangiocarcinoma. S.Y. Yoo, Pusan National University, KR |
|